73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in
Survey: Most women unaware of the signs of an aggressive form of breast cancer

Survey: Most women unaware of the signs of an aggressive form of breast cancer

by Ohio State University Comprehensive Cancer CenterDr. Ko Un Park consults with a patient at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Sol

Survey: Most women unaware of the signs of an aggressive form of breast cancer

by Ohio State University Comprehensive Cancer CenterDr. Ko Un Park consults with a patient at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Sol
New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar
Detailed diagnosis boosts child cancer survival

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi
Two cancer-causing genes work together to promote metastasis

Two cancer-causing genes work together to promote metastasis

byeLifeCredit: CC0 Public DomainCancer-promoting genes MYC and TWIST1 co-opt immune system cells to enable cancer cells to spread, but blocking a key step in this process can help prevent the di

Two cancer-causing genes work together to promote metastasis

byeLifeCredit: CC0 Public DomainCancer-promoting genes MYC and TWIST1 co-opt immune system cells to enable cancer cells to spread, but blocking a key step in this process can help prevent the di
Structural analysis reveals an unexpected mechanism for a cancer drug

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p
Step forward in leukemia treatment

Step forward in leukemia treatment

by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen

Step forward in leukemia treatment

by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen
Results mixed for twice-daily APBI in early breast cancer

Results mixed for twice-daily APBI in early breast cancer

(HealthDay)—Accelerated partial breast irradiation (APBI) delivered twice per day over one week to the tumor bed is noninferior to whole breast irradiation for preventing ipsilateral breast tumor recu

Results mixed for twice-daily APBI in early breast cancer

(HealthDay)—Accelerated partial breast irradiation (APBI) delivered twice per day over one week to the tumor bed is noninferior to whole breast irradiation for preventing ipsilateral breast tumor recu
Why some cancers affect only young women

Why some cancers affect only young women

byUniversity of GenevaCredit: CC0 Public DomainAmong several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an

Why some cancers affect only young women

byUniversity of GenevaCredit: CC0 Public DomainAmong several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an
Conversation tool to help cancer patients with treatment choices

Conversation tool to help cancer patients with treatment choices

byLeiden UniversityCredit: Pixabay/CC0 Public DomainResearchers at the Leiden Institute of Advanced Computer Science (LIACS) are collaborating on the development of a conversation tool for patie

Conversation tool to help cancer patients with treatment choices

byLeiden UniversityCredit: Pixabay/CC0 Public DomainResearchers at the Leiden Institute of Advanced Computer Science (LIACS) are collaborating on the development of a conversation tool for patie
What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha
Molecular delivery system developed at URI shows promise against bladder cancer

Molecular delivery system developed at URI shows promise against bladder cancer

byUniversity of Rhode IslandpHLIP-ICG can locate cancerous lesions and illuminate them with a fluorescent molecule, making them potentially easier for surgeons to see and remove. Credit: URIA re

Molecular delivery system developed at URI shows promise against bladder cancer

byUniversity of Rhode IslandpHLIP-ICG can locate cancerous lesions and illuminate them with a fluorescent molecule, making them potentially easier for surgeons to see and remove. Credit: URIA re